Full Press Release Details
STARBORN - 1 Clinical Trial Interim Update November 19, 2025
TARA - 002 IN LMS Interim STARBORN - 1 Data Update and OK - 432 Data Review
TARA - 002 Demonstrated Meaningful Results in LMs Patients Treated in the STARBORN - 1 Study BEFORE AFTER BEFORE AFTER 17 Medical photography from 2 patients pre - and post - treatment with TARA - 002 in STARBORN - 1 trial
Q&A 22 Jesse Shefferman Co - founder, Director, Chief Executive Officer Jacqueline Zummo, PhD Co - founder, Senior Vice President, Chief Scientific Operations Officer Jesse G.A. Jones, MD University of Alabama - Department of Neurosurgery and Radiology, and STARBORN - 1 study investigator